Pharmaceuticals and Healthcare Report Q3 2010 Market Research and Analysis June Update by ReportsandReports

DALLAS, June 23, 2010 - ReportsandReports announces it will carry Pharmaceuticals and Healthcare
Market Research Report June update in its store.

Bangladesh Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/bangladesh-
pharmaceuticals-and-healthcare-report-q3-2010/)

Out of the 16 key markets surveyed in BMI's Pharmaceuticals & Healthcare
Business Environment Ratings, Bangladesh moves up two places to occupy 14th
position in the table. This improvement sees it now placing above Pakistan
and Cambodia, th… June 2010 $ 530

Bulgaria Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/bulgaria-
pharmaceuticals-and-healthcare-report-q3-2010/)

BMI considers Bulgaria to be among the less attractive pharmaceutical
markets in Emerging Europe, a view largely enforced by poor market dynamics
and prolonged economic difficulties. In BMI's Pharmaceuticals & Healthcare
Business Environment Ratings for June 2010 $ 530

Kazakhstan Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/kazakhstan-
pharmaceuticals-and-healthcare-report-q3-2010/)

BMI retains its robust five-year growth forecast for the Kazakhstan
pharmaceutical market, with the US dollar value of the market rebounding on
the back of a resurgent local currency in 2010. Our forecast sees a strong
economy - driven by increasing oil June 2010 $ 530

Belgium Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/belgium-pharmaceuticals
-and-healthcare-report-q3-2010/)

Having received a somewhat lower compound score in Q310, Belgium is now
placed joint fifth in the Western Europe Pharmaceuticals & Healthcare
Business Environment Ratings (BER) matrix, on a par with the UK and below
Germany, Switzerland and new inclusio June 2010 $ 530

Moldova Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/moldova-pharmaceuticals
-and-healthcare-report-q3-2010/)

Moldova's pharmaceutical market was valued at US$208mn in 2009, and BMI
calculates that the market will post a compound annual growth rate (CAGR) of
4.95% between 2009 and 2014 in US dollar terms, increasing to 8.45% growth
between 2009 and 2019. Moldov June 2010 $ 530

Portugal Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/portugal-pharmaceuticals
-and-healthcare-report-q3-2010/)

Portugal's pharmaceutical sales reached a value of EUR3.62bn (US$5.10bn)
in 2009. It is BMI's view that the slowdown in drug market growth in Portugal
in recent years will continue in 2010, with drug sales expected to reach a
value of EUR3.64bn (US$5.27 June 2010 $ 530

Qatar Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/qatar-pharmaceuticals-
and-healthcare-report-q3-2010/)

The total pharmaceutical market in Qatar will rise from a value of
US$233mn in 2009 to US$419mn by 2014, at a CAGR of 12.45%. The proportion
of GDP accounted for by drug spending will be 0.26% by this time. Per-capita
spending on medicines will be US$22 June 2010 $ 530

Zimbabwe Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/zimbabwe-
pharmaceuticals-and-healthcare-report-q3-2010/)

Zimbabwe remains firmly at the bottom of BMI's Business Environment
Ratings for Q310, which looks at 19 key regional markets, now including
Ghana and Iraq. Although an improvement on last quart… June 2010 $ 530

Slovenia Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/slovenia-
pharmaceuticals-and-healthcare-report-q3-2010/)

In BMI's Business Environment Ratings (BER) table for Q310, Slovenia is
ranked 10th of the 20 markets assessed in the Emerging Europe region, down by
one place in relation to the previous quarter. Globally, Slovenia is ranked
38th out of 82… May 2010 $ 530

Italy Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/italy-pharmaceuticals-
and-healthcare-report-q3-2010/)

In BMI's latest Pharmaceuticals & Healthcare Business Environment Ratings
(BER), Italy remains the least attractive Western European market of the ten
surveyed. Despite being a large market, Italy is characterised by low levels
of growth, l… May 2010 $ 530

Taiwan Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/taiwan-pharmaceuticals-
and-healthcare-report-q3-2010/)

Taiwan's US$3.81bn pharmaceutical market is the sixth largest in Asia
Pacific, well below Australia (US$8.61bn), but slightly ahead of Indonesia
(US$3.66bn). Annual per-capita spending on medicines is US$165, just above
the regional average… May 2010 $ 530

Jordan Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/jordan-pharmaceuticals-
and-healthcare-report-q3-2010/)

The Jordan Association of Pharmaceutical Manufacturers states that the
pharmaceutical sector in Jordan is export driven, which a glance at the trade
balance confirms. There are 17 local pharmaceutical firms - the result of
major consolidati… May 2010 $ 530

Algeria Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/algeria-pharmaceuticals-
and-healthcare-report-q3-2010/)

BMI calculates the value of Algeria's pharmaceutical consumption to have
been DZD169.55bn (US$2.36bn) in 2009. The market is characterised by a
relatively low per-capita spend of US$68 and a large generics sector - 38%
of total drug expendi… May 2010 $ 530

Germany Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/germany-
pharmaceuticals-and-healthcare-report-q3-2010/)

Highlighting the effects of the impending patent cliff and the consequent
consumption of lower-value generic drugs in place of high-value patented
drugs, BMI calculates a decline in the growth of the German pharmaceutical
market. BMI calcul… May 2010 $ 530

Iran Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/iran-pharmaceuticals-
and-healthcare-report-q3-2010/)

In BMI's Middle East and Africa (MEA) Pharmaceutical Business Environment
Ratings (BERs) for Q310, Iran is once again found in eighth place. Compared
with its regional neighbours, Iran's score is buoyed by its growing
population and healthc… May 2010 $ 530

South Korea Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/south-korea-
pharmaceuticals-and-healthcare-report-q3-2010/)

In our latest Pharmaceutical and Healthcare Business Environment Ratings
(BERs), South Korea can be found in pole position of the 16 markets surveyed
in the Asia Pacific region, ahead of Japan and Australia. The upgrade is due
to a re-evalu… May 2010 $ 530

Indonesia Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/indonesia-
pharmaceuticals-and-healthcare-report-q3-2010/)

In the BMI Business Environment Rating matrix for Q310, we see Indonesia
continue to occupy 12th position of the 16 regional markets surveyed in the
Asia Pacific region. The country's pharmaceutical rating has risen to 47.2,
marking a margi… May 2010 $ 530

Turkey Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/turkey-pharmaceuticals-
and-healthcare-report-q3-2010/)

Turkey's pharmaceutical market remains one of the most attractive
long-term prospects for pharmaceutical companies, despite negative regulatory
changes over the past 12 months. In BMI's Business Environment Ratings for
Q310, Turkey is fourt… May 2010 $ 530

Sweden Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/sweden-pharmaceuticals-
and-healthcare-report-q3-2010/)

BMI considers Sweden one of the most attractive markets globally for
pharmaceutical companies. Among the 82 countries in BMI's Global Business
Environment Ratings, Sweden ranks fifth, behind the US, Germany, Canada and
Switzerland. Des… May 2010 $ 530

Estonia Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/estonia-
pharmaceuticals-and-healthcare-report-q3-2010/)

BMI views Estonia's pharmaceutical market as a mildly attractive
proposition for multinational drugmakers. Estonia ranks 11th in BMI's
Pharmaceuticals & Healthcare Business Environment Ratings for Emerging
Europe in Q310 and places 43rd on … May 2010 $ 530

(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if one exists.)

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific
websites. Our client list boasts almost all well-known publishers of such
reports across the globe. We as a third-party reseller of market research
reports employ a number of marketing tools, such as press releases,
email-marketing and effective search-engine optimization techniques to drive
revenues for our clients. We also provide 24/7 online and offline support
service to our customers.

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    www.reportsandreports.com/
    reportsnreports.wordpress.com/
<end_table